# Cholera

> The content on this page is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. If you have health concerns, consult a qualified healthcare professional. Medova is not a medical service provider.

Source: https://medova.health/en/knowledge/vaccines/cholera-vaccine · Language: en

## Vaccine Information

- Type: Inactivated
- Administration: Oral
- WHO Code: OCV
- Travel Recommended: Yes

**Pregnancy: Use only if clearly needed.**

Limited safety data in pregnancy. Oral killed whole-cell cholera vaccines (Dukoral, Shanchol) are inactivated and considered low-risk, but formal pregnancy studies are insufficient.


- WHO: "may be used in pregnant women if the potential benefit justifies the potential risk."

- Consider vaccination for pregnant women traveling to active cholera outbreak areas or refugee/disaster settings.

- Dukoral buffer contains sodium bicarbonate — no known concern for pregnancy.

**Breastfeeding: Safe.**

Oral cholera vaccines are inactivated and safe during breastfeeding. Maternal antibodies in breast milk may provide additional protection to the infant. No modification to breastfeeding schedule required.

**Pediatric use:**


- **Shanchol/Euvichol:** licensed from **1 year** of age. 2 oral doses, 2 weeks apart.

- **Dukoral:** licensed from **2 years** of age. Children 2–5 years: 3 doses (extra dose due to lower immune response). Children ≥6 years: 2 doses.

- Booster intervals differ: Dukoral every 6 months (children 2–5y) or every 2 years (≥6y). Shanchol: booster data limited.

- Dukoral: dissolve effervescent granules in 75 mL water (children) or 150 mL (adults). Do not eat or drink for 1 hour before and after.

**Geriatric use:**


- No specific age-related contraindications. Standard dosing applies.

- Efficacy may be reduced in immunocompromised elderly individuals.

- Cholera in elderly patients carries higher mortality risk — vaccination is particularly beneficial for at-risk elderly travelers.

## Side Effects

- Abdominal pain (Common)
- Anaphylaxis (Very rare) — Serious
- Angioedema (Very rare) — Serious
- Arthralgia (Rare)
- Chills (Uncommon)
- Diarrhea (Common)
- Dizziness (Rare)
- Drowsiness (Uncommon)
- Fatigue (Uncommon)
- Fever (Uncommon)
- Generalized rash (Rare)
- Headache (Uncommon)
- Insomnia (Uncommon)
- Loss of appetite (Uncommon)
- Lymphadenopathy (Rare)
- Malaise (Uncommon)
- Myalgia (Uncommon)
- Nausea (Common)
- Pruritus (Rare)
- Urticaria (Rare)
- Vomiting (Uncommon)

## Contraindications

- Acute febrile illness (Precaution)
- Age below minimum recommended (Absolute)
- Anaphylaxis after previous dose (Absolute)
- Allergy to vaccine component (Absolute)
- Pregnancy (Precaution)

## Vaccination Schedule

| Dose | Brand | Days from previous | Age range |
| --- | --- | --- | --- |
| Dose 1 | Shanchol | — | 1 years+ |
| Dose 2 | Shanchol | 14d | — |

## FAQ

**How many doses of Cholera are needed?**

The Cholera vaccination schedule consists of 2 dose(s).

**What are the side effects of Cholera?**

Common side effects include: Abdominal pain, Anaphylaxis, Angioedema, Arthralgia, Chills.

**Who should not get Cholera?**

Contraindications include: Acute febrile illness, Age below minimum recommended, Anaphylaxis after previous dose, Allergy to vaccine component, Pregnancy.

## Prevents

- [Cholera](https://medova.health/en/knowledge/diseases/cholera)

## Indications

- [South Sudan](https://medova.health/en/knowledge/countries/south-sudan): Recommended
- [India](https://medova.health/en/knowledge/countries/india): Recommended
- [Cameroon](https://medova.health/en/knowledge/countries/cameroon): Recommended
- [Senegal](https://medova.health/en/knowledge/countries/senegal): Recommended
- [Mali](https://medova.health/en/knowledge/countries/mali): Recommended
- [Niger](https://medova.health/en/knowledge/countries/niger): Recommended
- [Burkina Faso](https://medova.health/en/knowledge/countries/burkina-faso): Recommended
- [Chad](https://medova.health/en/knowledge/countries/chad): Recommended
- [Democratic Republic of the Congo](https://medova.health/en/knowledge/countries/democratic-republic-of-the-congo): Recommended
- [Kenya](https://medova.health/en/knowledge/countries/kenya): Recommended

## Sources & content verification

- Data sources: WHO Position Papers 2024 + CDC Pink Book 2024 + EMA SmPC
- [www.who.int](https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers)

---

The content on this page is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. If you have health concerns, consult a qualified healthcare professional. Medova is not a medical service provider.

[Full terms of use](https://medova.health/en/terms)
